Clinical Reviews in Allergy and Immunology

β₂-Agonists: Introduction
pp. 103-105(3)
Author: Anderson, Sandra

Current issues with β₂-adrenoceptor agonists: Historical background
pp. 107-117(11)
Author: Tattersfield, Anne

Current issues with β₂-adrenoceptor agonists: Pharmacology and molecular and cellular mechanisms
pp. 119-130(12)
Author: Anderson, Gary

Regulation of mast cells by β-agonists
pp. 131-141(11)
Author: Peachell, Peter

β₂-Agonists and bronchial hyperresponsiveness
pp. 143-161(19)
Authors: Page, Clive; Spina, Domenico

β₂-Agonists and exercise-induced asthma
pp. 163-180(18)
Authors: Anderson, Sandra; Caillaud, Corinne; Brannan, John

Recovery from bronchoconstriction and bronchodilator tolerance
pp. 181-196(16)
Authors: Haney, Sarah; Hancox, Robert

Clinical concerns with inhaled β₂-agonists: Adult asthma
pp. 197-207(11)
Author: Cockcroft, D.

β₂-Agonists for asthma: The pediatric perspective
pp. 209-218(10)
Authors: Subbarao, Padmaja; Ratjen, Felix

Systematic review of clinical outcomes in chronic obstructive pulmonary disease: β-Agonist use compared with anticholinergics and inhaled corticosteroids
pp. 219-230(12)
Authors: Salpeter, Shelley; Buckley, Nicholas

Interactions between corticosteroids and β₂-agonists
pp. 231-245(15)
Author: Hancox, Robert

Pharmacogenetics of β₂-agonist drugs in asthma
pp. 247-258(12)
Author: Taylor, D.

β₂-Agonists at the olympic games
pp. 259-268(10)
Author: Fitch, Kenneth

Serious adverse events and death associated with treatment using long-acting β-agonists
pp. 269-278(10)
Author: Martinez, Fernando

Concluding remarks: Can we explain the associations of β-agonists with asthma mortality? A hypothesis
pp. 279-287(9)
Author: Hancox, Robert